OREGA Biotech’s interleukin-17 patent to be granted in the US

Orega_actu
IL-17B program to be presented at AACR 2017
24 March 2017

OREGA Biotech’s interleukin-17 patent to be granted in the US

Orega_actu

Receipt of a Notice of Allowance from USPTO for a strategic patent application related to OREGA’s IL-17 program